New Psoriasis Rx Gets Green Light
The US Food and Drug Administration (FDA) has approved a new plaque psoriasis drug.
Enbrel Biosimilar Gets Green Light
Enbrel's new biosimilar recently got the green light it needed to treat several inflammatory health conditions.